Global and United States Human Vaccine Market Insights, Forecast to 2027

Global and United States Human Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Human Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Vaccine Market Size Growth Rate by Type
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Market by Application
1.3.1 Global Human Vaccine Market Size Growth Rate by Application
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Human Vaccine Revenue 2016-2027
2.1.2 Global Human Vaccine Sales 2016-2027
2.2 Global Human Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Human Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Human Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Human Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Human Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Human Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Human Vaccine Revenue Forecast by Region (2022-2027)
3 Global Human Vaccine Competitor Landscape by Players
3.1 Global Top Human Vaccine Manufacturers by Sales
3.1.1 Global Human Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Human Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Human Vaccine Manufacturers by Revenue
3.2.1 Key Human Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Human Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Human Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Human Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Human Vaccine Revenue in 2020
3.2.6 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Human Vaccine Price by Manufacturers
3.4 Global Human Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Human Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Human Vaccine Market Size by Type (2016-2021)
4.1.1 Global Human Vaccine Sales by Type (2016-2021)
4.1.2 Global Human Vaccine Revenue by Type (2016-2021)
4.1.3 Human Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Human Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Human Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Human Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Human Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Human Vaccine Market Size by Application (2016-2021)
5.1.1 Global Human Vaccine Sales by Application (2016-2021)
5.1.2 Global Human Vaccine Revenue by Application (2016-2021)
5.1.3 Human Vaccine Price by Application (2016-2021)
5.2 Human Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Human Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Human Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Vaccine Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Human Vaccine Market Size YoY Growth 2016-2027
6.1.1 United States Human Vaccine Sales YoY Growth 2016-2027
6.1.2 United States Human Vaccine Revenue YoY Growth 2016-2027
6.1.3 United States Human Vaccine Market Share in Global Market 2016-2027
6.2 United States Human Vaccine Market Size by Players (International and Local Players)
6.2.1 United States Top Human Vaccine Players by Sales (2016-2021)
6.2.2 United States Top Human Vaccine Players by Revenue (2016-2021)
6.3 United States Human Vaccine Historic Market Review by Type (2016-2021)
6.3.1 United States Human Vaccine Sales Market Share by Type (2016-2021)
6.3.2 United States Human Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 United States Human Vaccine Price by Type (2016-2021)
6.4 United States Human Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Human Vaccine Sales Forecast by Type (2022-2027)
6.4.2 United States Human Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 United States Human Vaccine Price Forecast by Type (2022-2027)
6.5 United States Human Vaccine Historic Market Review by Application (2016-2021)
6.5.1 United States Human Vaccine Sales Market Share by Application (2016-2021)
6.5.2 United States Human Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 United States Human Vaccine Price by Application (2016-2021)
6.6 United States Human Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Human Vaccine Sales Forecast by Application (2022-2027)
6.6.2 United States Human Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 United States Human Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Human Vaccine Market Size YoY Growth 2016-2027
7.2 North America Human Vaccine Market Facts & Figures by Country
7.2.1 North America Human Vaccine Sales by Country (2016-2021)
7.2.2 North America Human Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Human Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Human Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Human Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Human Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Human Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Human Vaccine Market Facts & Figures by Country
9.2.1 Europe Human Vaccine Sales by Country (2016-2021)
9.2.2 Europe Human Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Human Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Human Vaccine Market Facts & Figures by Country
10.2.1 Latin America Human Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Human Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Human Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Human Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Human Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 CNBG
12.1.1 CNBG Corporation Information
12.1.2 CNBG Description and Business Overview
12.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CNBG Human Vaccine Products Offered
12.1.5 CNBG Recent Development
12.2 Changsheng Life
12.2.1 Changsheng Life Corporation Information
12.2.2 Changsheng Life Description and Business Overview
12.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Changsheng Life Human Vaccine Products Offered
12.2.5 Changsheng Life Recent Development
12.3 Zhifei
12.3.1 Zhifei Corporation Information
12.3.2 Zhifei Description and Business Overview
12.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Zhifei Human Vaccine Products Offered
12.3.5 Zhifei Recent Development
12.4 ChengDa Bio
12.4.1 ChengDa Bio Corporation Information
12.4.2 ChengDa Bio Description and Business Overview
12.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 ChengDa Bio Human Vaccine Products Offered
12.4.5 ChengDa Bio Recent Development
12.5 Kangtai
12.5.1 Kangtai Corporation Information
12.5.2 Kangtai Description and Business Overview
12.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Kangtai Human Vaccine Products Offered
12.5.5 Kangtai Recent Development
12.6 SINOVAC BIOTECH
12.6.1 SINOVAC BIOTECH Corporation Information
12.6.2 SINOVAC BIOTECH Description and Business Overview
12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 SINOVAC BIOTECH Human Vaccine Products Offered
12.6.5 SINOVAC BIOTECH Recent Development
12.7 Hissen
12.7.1 Hissen Corporation Information
12.7.2 Hissen Description and Business Overview
12.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hissen Human Vaccine Products Offered
12.7.5 Hissen Recent Development
12.8 Walvax Biotechnology
12.8.1 Walvax Biotechnology Corporation Information
12.8.2 Walvax Biotechnology Description and Business Overview
12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Walvax Biotechnology Human Vaccine Products Offered
12.8.5 Walvax Biotechnology Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Description and Business Overview
12.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GSK Human Vaccine Products Offered
12.9.5 GSK Recent Development
12.10 SANOFI
12.10.1 SANOFI Corporation Information
12.10.2 SANOFI Description and Business Overview
12.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 SANOFI Human Vaccine Products Offered
12.10.5 SANOFI Recent Development
12.11 CNBG
12.11.1 CNBG Corporation Information
12.11.2 CNBG Description and Business Overview
12.11.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CNBG Human Vaccine Products Offered
12.11.5 CNBG Recent Development
12.12 NuoCheng Bio
12.12.1 NuoCheng Bio Corporation Information
12.12.2 NuoCheng Bio Description and Business Overview
12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 NuoCheng Bio Products Offered
12.12.5 NuoCheng Bio Recent Development
12.13 Hualan Bio
12.13.1 Hualan Bio Corporation Information
12.13.2 Hualan Bio Description and Business Overview
12.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Hualan Bio Products Offered
12.13.5 Hualan Bio Recent Development
12.14 Tiantan biological
12.14.1 Tiantan biological Corporation Information
12.14.2 Tiantan biological Description and Business Overview
12.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Tiantan biological Products Offered
12.14.5 Tiantan biological Recent Development
12.15 Changchun Baike
12.15.1 Changchun Baike Corporation Information
12.15.2 Changchun Baike Description and Business Overview
12.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Changchun Baike Products Offered
12.15.5 Changchun Baike Recent Development
12.16 Adimmune
12.16.1 Adimmune Corporation Information
12.16.2 Adimmune Description and Business Overview
12.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Adimmune Products Offered
12.16.5 Adimmune Recent Development
12.17 Zhongyianke Biotech
12.17.1 Zhongyianke Biotech Corporation Information
12.17.2 Zhongyianke Biotech Description and Business Overview
12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Zhongyianke Biotech Products Offered
12.17.5 Zhongyianke Biotech Recent Development
12.18 Bharat Biotech
12.18.1 Bharat Biotech Corporation Information
12.18.2 Bharat Biotech Description and Business Overview
12.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Bharat Biotech Products Offered
12.18.5 Bharat Biotech Recent Development
12.19 Bavarian Nordic
12.19.1 Bavarian Nordic Corporation Information
12.19.2 Bavarian Nordic Description and Business Overview
12.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Bavarian Nordic Products Offered
12.19.5 Bavarian Nordic Recent Development
12.20 Sanofi-Pasteur
12.20.1 Sanofi-Pasteur Corporation Information
12.20.2 Sanofi-Pasteur Description and Business Overview
12.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Sanofi-Pasteur Products Offered
12.20.5 Sanofi-Pasteur Recent Development
12.21 Indian Immunologicals
12.21.1 Indian Immunologicals Corporation Information
12.21.2 Indian Immunologicals Description and Business Overview
12.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Indian Immunologicals Products Offered
12.21.5 Indian Immunologicals Recent Development
12.22 KANGH
12.22.1 KANGH Corporation Information
12.22.2 KANGH Description and Business Overview
12.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.22.4 KANGH Products Offered
12.22.5 KANGH Recent Development
12.23 Henan Grand Biopharma
12.23.1 Henan Grand Biopharma Corporation Information
12.23.2 Henan Grand Biopharma Description and Business Overview
12.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Henan Grand Biopharma Products Offered
12.23.5 Henan Grand Biopharma Recent Development
12.24 ZhongKe Biopharm
12.24.1 ZhongKe Biopharm Corporation Information
12.24.2 ZhongKe Biopharm Description and Business Overview
12.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.24.4 ZhongKe Biopharm Products Offered
12.24.5 ZhongKe Biopharm Recent Development
12.25 Zhuoyi Biological
12.25.1 Zhuoyi Biological Corporation Information
12.25.2 Zhuoyi Biological Description and Business Overview
12.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Zhuoyi Biological Products Offered
12.25.5 Zhuoyi Biological Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Human Vaccine Industry Trends
13.2 Human Vaccine Market Drivers
13.3 Human Vaccine Market Challenges
13.4 Human Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Human Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Varicella
Table 3. Major Manufacturers of Influenza
Table 4. Major Manufacturers of Polio
Table 5. Major Manufacturers of Hepatitis A
Table 6. Major Manufacturers of Rabies
Table 7. Major Manufacturers of BCG
Table 8. Major Manufacturers of Hepatitis B
Table 9. Major Manufacturers of Pertussis, Diphtheria, Tetanus
Table 10. Major Manufacturers of Pneumococcal
Table 11. Major Manufacturers of Rota vaccine
Table 12. Global Human Vaccine Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 13. Global Human Vaccine Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 14. Global Human Vaccine Sales by Regions (2016-2021) & (M Doses)
Table 15. Global Human Vaccine Sales Market Share by Regions (2016-2021)
Table 16. Global Human Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 17. Global Human Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 18. Global Human Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 19. Global Human Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 20. Global Human Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 21. Global Human Vaccine Sales by Manufacturers (2016-2021) (M Doses)
Table 22. Global Human Vaccine Sales Share by Manufacturers (2016-2021)
Table 23. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 24. Human Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 25. Human Vaccine Revenue Share by Manufacturers (2016-2021)
Table 26. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 27. Global Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2020)
Table 28. Key Manufacturers Human Vaccine Price (2016-2021) (USD/Dose)
Table 29. Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Human Vaccine Product Type
Table 31. Date of International Manufacturers Enter into Human Vaccine Market
Table 32. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 33. Global Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 34. Global Human Vaccine Sales Share by Type (2016-2021)
Table 35. Global Human Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 36. Global Human Vaccine Revenue Share by Type (2016-2021)
Table 37. Human Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 38. Global Human Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 39. Global Human Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 40. Global Human Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 41. Global Human Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 42. Global Human Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 43. Global Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 44. Global Human Vaccine Sales Share by Application (2016-2021)
Table 45. Global Human Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 46. Global Human Vaccine Revenue Share by Application (2016-2021)
Table 47. Human Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose)
Table 48. Global Human Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 49. Global Human Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 50. Global Human Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 51. Global Human Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 52. Global Human Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose)
Table 53. United States Human Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 54. United States Human Vaccine Sales Share by Company (2016-2021)
Table 55. United States Human Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 56. United States Human Vaccine Revenue Share by Company (2016-2021)
Table 57. United States Human Vaccine Sales (M Doses) by Type (2016-2021)
Table 58. United States Human Vaccine Sales Share by Type (2016-2021)
Table 59. United States Human Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 60. United States Human Vaccine Price (USD/Dose) by Type (2016-2021)
Table 61. United States Human Vaccine Sales (M Doses) by Type (2022-2027)
Table 62. United States Human Vaccine Sales Share by Type (2022-2027)
Table 63. United States Human Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 64. United States Human Vaccine Revenue Share by Type (2022-2027)
Table 65. United States Human Vaccine Price (USD/Dose) by Type (2022-2027)
Table 66. United States Human Vaccine Sales (M Doses) by Application (2016-2021)
Table 67. United States Human Vaccine Sales Share by Application (2016-2021)
Table 68. United States Human Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 69. United States Human Vaccine Price (USD/Dose) by Application (2016-2021)
Table 70. United States Human Vaccine Sales (M Doses) by Application (2022-2027)
Table 71. United States Human Vaccine Sales Share by Application (2022-2027)
Table 72. United States Human Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 73. United States Human Vaccine Revenue Share by Application (2022-2027)
Table 74. United States Human Vaccine Price (USD/Dose) by Application (2022-2027)
Table 75. North America Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 76. North America Human Vaccine Sales Market Share by Country (2016-2021)
Table 77. North America Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. North America Human Vaccine Revenue Market Share by Country (2016-2021)
Table 79. Asia Pacific Human Vaccine Sales by Region (2016-2021) & (M Doses)
Table 80. Asia Pacific Human Vaccine Sales Market Share by Region (2016-2021)
Table 81. Asia Pacific Human Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Human Vaccine Revenue Market Share by Region (2016-2021)
Table 83. Europe Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 84. Europe Human Vaccine Sales Market Share by Country (2016-2021)
Table 85. Europe Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Europe Human Vaccine Revenue Market Share by Country (2016-2021)
Table 87. Latin America Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 88. Latin America Human Vaccine Sales Market Share by Country (2016-2021)
Table 89. Latin Americaa Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 90. Latin America Human Vaccine Revenue Market Share by Country (2016-2021)
Table 91. Middle East and Africa Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 92. Middle East and Africa Human Vaccine Sales Market Share by Country (2016-2021)
Table 93. Middle East and Africa Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 94. Middle East and Africa Human Vaccine Revenue Market Share by Country (2016-2021)
Table 95. CNBG Corporation Information
Table 96. CNBG Description and Business Overview
Table 97. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 98. CNBG Human Vaccine Product
Table 99. CNBG Recent Development
Table 100. Changsheng Life Corporation Information
Table 101. Changsheng Life Description and Business Overview
Table 102. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 103. Changsheng Life Product
Table 104. Changsheng Life Recent Development
Table 105. Zhifei Corporation Information
Table 106. Zhifei Description and Business Overview
Table 107. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 108. Zhifei Product
Table 109. Zhifei Recent Development
Table 110. ChengDa Bio Corporation Information
Table 111. ChengDa Bio Description and Business Overview
Table 112. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. ChengDa Bio Product
Table 114. ChengDa Bio Recent Development
Table 115. Kangtai Corporation Information
Table 116. Kangtai Description and Business Overview
Table 117. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Kangtai Product
Table 119. Kangtai Recent Development
Table 120. SINOVAC BIOTECH Corporation Information
Table 121. SINOVAC BIOTECH Description and Business Overview
Table 122. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. SINOVAC BIOTECH Product
Table 124. SINOVAC BIOTECH Recent Development
Table 125. Hissen Corporation Information
Table 126. Hissen Description and Business Overview
Table 127. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Hissen Product
Table 129. Hissen Recent Development
Table 130. Walvax Biotechnology Corporation Information
Table 131. Walvax Biotechnology Description and Business Overview
Table 132. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Walvax Biotechnology Product
Table 134. Walvax Biotechnology Recent Development
Table 135. GSK Corporation Information
Table 136. GSK Description and Business Overview
Table 137. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. GSK Product
Table 139. GSK Recent Development
Table 140. SANOFI Corporation Information
Table 141. SANOFI Description and Business Overview
Table 142. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. SANOFI Product
Table 144. SANOFI Recent Development
Table 145. Rong An Corporation Information
Table 146. Rong An Description and Business Overview
Table 147. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 148. Rong An Product
Table 149. Rong An Recent Development
Table 150. NuoCheng Bio Corporation Information
Table 151. NuoCheng Bio Description and Business Overview
Table 152. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 153. NuoCheng Bio Product
Table 154. NuoCheng Bio Recent Development
Table 155. Hualan Bio Corporation Information
Table 156. Hualan Bio Description and Business Overview
Table 157. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Hualan Bio Product
Table 159. Hualan Bio Recent Development
Table 160. Tiantan biological Corporation Information
Table 161. Tiantan biological Description and Business Overview
Table 162. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. Tiantan biological Product
Table 164. Tiantan biological Recent Development
Table 165. Changchun Baike Corporation Information
Table 166. Changchun Baike Description and Business Overview
Table 167. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 168. Changchun Baike Product
Table 169. Changchun Baike Recent Development
Table 170. Adimmune Corporation Information
Table 171. Adimmune Description and Business Overview
Table 172. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 173. Adimmune Product
Table 174. Adimmune Recent Development
Table 175. Zhongyianke Biotech Corporation Information
Table 176. Zhongyianke Biotech Description and Business Overview
Table 177. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 178. Zhongyianke Biotech Product
Table 179. Zhongyianke Biotech Recent Development
Table 180. Bharat Biotech Corporation Information
Table 181. Bharat Biotech Description and Business Overview
Table 182. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 183. Bharat Biotech Product
Table 184. Bharat Biotech Recent Development
Table 185. Bavarian Nordic Corporation Information
Table 186. Bavarian Nordic Description and Business Overview
Table 187. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 188. Bavarian Nordic Product
Table 189. Bavarian Nordic Recent Development
Table 190. Sanofi-Pasteur Corporation Information
Table 191. Sanofi-Pasteur Description and Business Overview
Table 192. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 193. Sanofi-Pasteur Product
Table 194. Sanofi-Pasteur Recent Development
Table 195. Indian Immunologicals Corporation Information
Table 196. Indian Immunologicals Description and Business Overview
Table 197. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 198. Indian Immunologicals Product
Table 199. Indian Immunologicals Recent Development
Table 200. KANGH Corporation Information
Table 201. KANGH Description and Business Overview
Table 202. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 203. KANGH Product
Table 204. KANGH Recent Development
Table 205. Henan Grand Biopharma Corporation Information
Table 206. Henan Grand Biopharma Description and Business Overview
Table 207. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 208. Henan Grand Biopharma Product
Table 209. Henan Grand Biopharma Recent Development
Table 210. ZhongKe Biopharm Corporation Information
Table 211. ZhongKe Biopharm Description and Business Overview
Table 212. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 213. ZhongKe Biopharm Product
Table 214. ZhongKe Biopharm Recent Development
Table 215. Zhuoyi Biological Corporation Information
Table 216. Zhuoyi Biological Description and Business Overview
Table 217. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
T

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs